Since USP1 has been shown to regulate other targets, such as: KPNA2, that drive breast cancer metastasis, targeting this enzyme may be beneficial in the treatment of breast cancer patients, more specifically, TNBCs. This evidence concerns the gene USP1 and breast carcinoma.